30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Metacrine, Inc. (MTCR)

Track

Stock chart
Ticker: MTCR Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Klassen Preston
President & CEO
1 sale — total 157,266 USD
Sale 26 Jan 2023
Value US$1,041,828.43 | Price 467.25 | Shares 18,579
Sale 26 Jan 2023
Value US$396,022.45 | Price 276.04 | Shares 51,334
Buy 21 Dec 2022
Value US$48,039.60 | Price 0.40 | Shares 120,099
Buy 20 Dec 2022
Value US$19,001.25 | Price 0.38 | Shares 50,122
Buy 19 Dec 2022
Value US$40,553.60 | Price 0.40 | Shares 101,384
Buy 9 Nov 2022
Value US$15,528.24 | Price 0.39 | Shares 39,816
Buy 8 Nov 2022
Value US$200.00 | Price 0.40 | Shares 500
Buy 7 Nov 2022
Value US$52,345.77 | Price 0.42 | Shares 123,954
Buy 28 Oct 2022
Value US$17,999.80 | Price 0.40 | Shares 45,022
Buy 27 Oct 2022
Value US$299,327.73 | Price 0.39 | Shares 767,507
Buy 26 Oct 2022
Value US$208,222.98 | Price 0.35 | Shares 588,533
Buy 25 Oct 2022
Value US$175,596.42 | Price 0.35 | Shares 499,279
Buy 24 Oct 2022
Value US$59,280.36 | Price 0.34 | Shares 174,354
Sale 19 Apr 2022
Value US$593.07 | Price 0.51 | Shares 1,173
Sale 19 Apr 2022
Value US$21,879.01 | Price 0.50 | Shares 43,575
Sale 25 Oct 2021
Value US$805,972.30 | Price 1.49 | Shares 540,667
Sale 22 Oct 2021
Value US$122,929.84 | Price 1.64 | Shares 75,035
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$195,494.00 | Price 13.00 | Shares 15,038
Buy 18 Sep 2020
Value US$2,794,506.00 | Price 13.00 | Shares 214,962
Buy 18 Sep 2020
Value US$195,494.00 | Price 13.00 | Shares 15,038
Buy 18 Sep 2020
Value US$2,794,506.00 | Price 13.00 | Shares 214,962
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$260,000.00 | Price 13.00 | Shares 20,000
Buy 18 Sep 2020
Value US$2,730,000.00 | Price 13.00 | Shares 210,000
Buy 18 Sep 2020
Value US$260,000.00 | Price 13.00 | Shares 20,000
Buy 18 Sep 2020
Value US$2,730,000.00 | Price 13.00 | Shares 210,000
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$9,999,990.00 | Price 13.00 | Shares 769,230
Buy 18 Sep 2020
Value US$2,990,000.00 | Price 13.00 | Shares 230,000
Buy 18 Sep 2020
Value US$2,990,000.00 | Price 13.00 | Shares 230,000
Buy 18 Sep 2020
Value US$499,993.00 | Price 13.00 | Shares 38,461
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-27 2023-01-26 S Sale
Klassen Preston

President & CEO

Executive Director
18,579 -15.9%
467.25
US$1,041,828 		18,579 -15.9% 467.25 US$1,041,828
2023-01-27 2023-01-26 S Sale
York Michael

Chief Business Officer

Officer
51,334 -45.3%
276.04
US$396,022 		51,334 -45.3% 276.04 US$396,022
2022-12-21 2022-12-21 B Purchase
2.9
Leonard Braden Michael
Large shareholder
81,595 -14.7%
128.13
US$2,157,586 		81,595 -14.7% 128.13 US$2,157,586
2022-12-21 2022-12-20 B Purchase
2.9
Leonard Braden Michael
Large shareholder
50,122 +0.8%
0.38
US$19,001 		50,122 +0.8% 0.38 US$19,001
2022-12-21 2022-12-19 B Purchase
2.9
Leonard Braden Michael
Large shareholder
101,384 +1.7%
0.40
US$40,554 		101,384 +1.7% 0.40 US$40,554
2022-11-09 2022-11-09 B Purchase
2.9
Leonard Braden Michael
Large shareholder
39,816 +0.7%
0.39
US$15,528 		39,816 +0.7% 0.39 US$15,528
2022-11-09 2022-11-08 B Purchase
2.9
Leonard Braden Michael
Large shareholder
500 +0.0%
0.40
US$200 		500 +0.0% 0.40 US$200
2022-11-09 2022-11-07 B Purchase
2.9
Leonard Braden Michael
Large shareholder
123,954 +2.2%
0.42
US$52,346 		123,954 +2.2% 0.42 US$52,346
2022-10-31 2022-10-28 B Purchase
2.9
Leonard Braden Michael
Large shareholder
45,022 +0.8%
0.40
US$18,000 		45,022 +0.8% 0.40 US$18,000
2022-10-31 2022-10-27 B Purchase
2.9
Leonard Braden Michael
Large shareholder
767,507 +15.6%
0.39
US$299,328 		767,507 +15.6% 0.39 US$299,328
2022-10-26 2022-10-26 B Purchase
2.9
Leonard Braden Michael
Large shareholder
588,533 +13.6%
0.35
US$208,223 		588,533 +13.6% 0.35 US$208,223
2022-10-26 2022-10-25 B Purchase
2.9
Leonard Braden Michael
Large shareholder
499,279 +13.1%
0.35
US$175,596 		499,279 +13.1% 0.35 US$175,596
2022-10-26 2022-10-24 B Purchase
2.9
Leonard Braden Michael
Large shareholder
174,354 +4.8%
0.34
US$59,280 		174,354 +4.8% 0.34 US$59,280
2022-04-20 2022-04-19 S Sale
Klassen Preston

President & CEO

Executive Director
1,173 -0.1%
0.51
US$593 		1,173 -0.1% 0.51 US$593
2022-04-20 2022-04-19 S Sale
Klassen Preston

President & CEO

Executive Director
43,575 -4.5%
0.50
US$21,879 		43,575 -4.5% 0.50 US$21,879
2021-10-26 2021-10-25 S Sale
0.6
venBio Global Strategic Fund, L.P.
Large shareholder
540,667 -18.1%
1.49
US$805,972 		540,667 -18.1% 1.49 US$805,972
2021-10-26 2021-10-22 S Sale
0.6
venBio Global Strategic Fund, L.P.
Large shareholder
75,035 -2.5%
1.64
US$122,930 		75,035 -2.5% 1.64 US$122,930
2020-09-22 2020-09-18 B Purchase
2.1
Sonsini Peter W.
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.5
BASKETT FOREST
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.7
Makhzoumi Mohamad
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
3.9
Walker Paul Edward
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.1
MAKOWER JOSHUA
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.4
SANDELL SCOTT D
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
1.2
New Enterprise Associates 16, L.P.
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
1.9
Polaris Management Co. VII, L.L.C.
Large shareholder
15,038 +inf%
13.00
US$195,494 		15,038 +inf% 13.00 US$195,494
2020-09-22 2020-09-18 B Purchase
2.5
Nashat Amir
Non-Executive Director Large shareholder
15,038 +inf%
13.00
US$195,494 		15,038 +inf% 13.00 US$195,494
2020-09-22 2020-09-18 B Purchase
3.5
Chang Carmen
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
3.2
Burow Kristina
Non-Executive Director
20,000 +14.4%
13.00
US$260,000 		20,000 +14.4% 13.00 US$260,000
2020-09-22 2020-09-18 B Purchase
3.2
Burow Kristina
Non-Executive Director
210,000 +8.2%
13.00
US$2,730,000 		210,000 +8.2% 13.00 US$2,730,000
2020-09-22 2020-09-18 B Purchase
ARCH Venture Fund VIII, L.P.
Large shareholder
20,000 +14.4%
13.00
US$260,000 		20,000 +14.4% 13.00 US$260,000
2020-09-22 2020-09-18 B Purchase
ARCH Venture Fund VIII, L.P.
Large shareholder
210,000 +8.2%
13.00
US$2,730,000 		210,000 +8.2% 13.00 US$2,730,000
2020-09-22 2020-09-18 B Purchase
1.5
Behbahani Ali
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.6
Florence Anthony A. Jr.
Large shareholder
769,230 +33.6%
13.00
US$9,999,990 		769,230 +33.6% 13.00 US$9,999,990
2020-09-22 2020-09-18 B Purchase
2.5
Nashat Amir
Non-Executive Director Large shareholder
214,962 +inf%
13.00
US$2,794,506 		214,962 +inf% 13.00 US$2,794,506
2020-09-22 2020-09-18 B Purchase
Adelman Robert J
Non-Executive Director Large shareholder
230,000 +inf%
13.00
US$2,990,000 		230,000 +inf% 13.00 US$2,990,000
2020-09-22 2020-09-18 B Purchase
1.9
Polaris Management Co. VII, L.L.C.
Large shareholder
214,962 +inf%
13.00
US$2,794,506 		214,962 +inf% 13.00 US$2,794,506
2020-09-22 2020-09-18 B Purchase
0.6
venBio Global Strategic Fund, L.P.

See Remarks

Large shareholder
230,000 +inf%
13.00
US$2,990,000 		230,000 +inf% 13.00 US$2,990,000
2020-09-18 2020-09-18 B Purchase
Alexandria Venture Investments, LLC
Large shareholder
38,461 +3.0%
13.00
US$499,993 		38,461 +3.0% 13.00 US$499,993
Explore more

More insider trading research around Metacrine, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America